Ha habido 50 transacciones internas recientes registradas para Arcellx, Inc. (ACLX), incluyendo 11 compras y 34 ventas. El total de compras internas fue valorado en $5.5M y el total de ventas internas en $55.44M.
Internos destacados con actividad reciente incluyen Gilson Michelle, Elghandour Rami, Lubner David Charles. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ACLX
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-03-17 |
Gilson Michelle |
Chief Financial Officer |
Donación (Otorgada) |
5,000 |
- |
- |
28,938 |
| 2026-03-04 |
Elghandour Rami |
See Remarks |
Donación (Otorgada) |
101,164 |
- |
- |
174,887 |
| 2026-02-27 |
Elghandour Rami |
See Remarks |
Venta Informativa |
89,916 |
$113.92 |
$10.24M |
276,051 |
| 2026-02-25 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
11,219 |
$113.82 |
$1.28M |
33,938 |
| 2026-02-19 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
100 |
$69.38 |
$6.94K |
45,157 |
| 2026-02-17 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
4,150 |
$70.01 |
$290.55K |
53,541 |
| 2026-02-11 |
Elghandour Rami |
See Remarks |
Donación (Otorgada) |
218,500 |
- |
- |
563,967 |
| 2026-01-20 |
Lubner David Charles |
Director |
Venta Informativa |
6,000 |
$75.00 |
$450K |
21,659 |
| 2026-01-14 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
5,882 |
$68.51 |
$403K |
23,749 |
| 2026-01-13 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
7,437 |
$65.51 |
$487.21K |
29,631 |
| 2026-01-12 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
6,131 |
$64.15 |
$393.29K |
37,068 |
| 2026-01-06 |
Elghandour Rami |
See Remarks |
Ejercicio de Opciones (Venta) |
55,991 |
- |
- |
167,973 |
| 2026-01-06 |
Heery Christopher |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
13,064 |
- |
- |
39,194 |
| 2026-01-06 |
Gilson Michelle |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
20,530 |
- |
- |
61,590 |
| 2026-01-03 |
Elghandour Rami |
See Remarks |
Ejercicio de Opciones (Venta) |
53,098 |
- |
- |
- |
| 2026-01-03 |
Heery Christopher |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
16,520 |
- |
- |
- |
| 2026-01-03 |
Gilson Michelle |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
15,340 |
- |
- |
- |
| 2026-01-02 |
Elghandour Rami |
See Remarks |
Ejercicio de Opciones (Venta) |
55,459 |
- |
- |
55,459 |
| 2026-01-02 |
Heery Christopher |
Chief Medical Officer |
Ejercicio de Opciones (Venta) |
13,021 |
- |
- |
13,021 |
| 2026-01-02 |
Gilson Michelle |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
20,496 |
- |
- |
20,496 |
| 2025-11-17 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
340 |
$90.00 |
$30.6K |
284 |
| 2025-10-15 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
5,364 |
$91.04 |
$488.32K |
8,466 |
| 2025-10-06 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
1,064 |
$86.22 |
$91.73K |
13,830 |
| 2025-10-03 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
4,882 |
$86.00 |
$419.87K |
14,894 |
| 2025-09-30 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
1,530 |
$82.20 |
$125.76K |
624 |
| 2025-09-29 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
73 |
$80.16 |
$5.85K |
21,658 |
| 2025-09-26 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
12,396 |
$80.12 |
$993.16K |
21,731 |
| 2025-09-19 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
300 |
$80.00 |
$24K |
34,127 |
| 2025-09-18 |
Heery Christopher |
Chief Medical Officer |
Venta Informativa |
3,343 |
$80.01 |
$267.47K |
34,427 |
| 2025-08-28 |
Elghandour Rami |
See Remarks |
Retención Fiscal de RSU |
546,938 |
$70.25 |
$38.42M |
617,919 |
| 2025-08-12 |
Behbahani Ali |
Director |
Otro (Compra) |
1,586 |
- |
- |
1,925 |
| 2025-06-10 |
Patel Kavita |
Director |
Venta Informativa |
1,500 |
$67.36 |
$101.04K |
- |
| 2025-05-29 |
Galligan Andrew H |
Director |
Concesión de RSU |
1,784 |
$63.68 |
$113.61K |
1,784 |
| 2025-05-29 |
Lubner David Charles |
Director |
Concesión de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Carroll Jill |
Director |
Concesión de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Behbahani Ali |
Director |
Concesión de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Ware Olivia C |
Director |
Concesión de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Patel Kavita |
Director |
Concesión de RSU |
9,174 |
$63.68 |
$584.2K |
9,174 |
| 2025-05-29 |
Myers Kristin |
Director |
Concesión de RSU |
1,784 |
$63.68 |
$113.61K |
1,784 |
| 2025-05-27 |
Gilson Michelle |
Chief Financial Officer |
Venta Informativa |
8,449 |
$64.38 |
$543.91K |
19,776 |
| 2025-05-23 |
Gilson Michelle |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
22,429 |
- |
- |
- |
| 2025-05-20 |
Patel Kavita |
Director |
Venta Informativa |
1,500 |
$58.43 |
$87.65K |
- |
| 2025-04-29 |
Patel Kavita |
Director |
Venta Informativa |
1,500 |
$64.20 |
$96.3K |
- |
| 2025-04-08 |
Patel Kavita |
Director |
Venta Informativa |
1,500 |
$57.50 |
$86.25K |
- |
| 2025-03-18 |
Patel Kavita |
Director |
Venta Informativa |
1,500 |
$71.64 |
$107.46K |
- |
| 2025-03-18 |
Galligan Andrew H |
Director |
Desconocido |
- |
- |
- |
5,000 |
| 2025-03-18 |
Galligan Andrew H |
Director |
Concesión de RSU |
16,829 |
$69.87 |
$1.18M |
16,829 |
| 2025-03-18 |
Myers Kristin |
Officer |
Desconocido |
- |
- |
- |
- |
| 2025-03-18 |
Myers Kristin |
Director |
Concesión de RSU |
16,829 |
$69.87 |
$1.18M |
16,829 |
| 2025-02-27 |
Elghandour Rami |
See Remarks |
Concesión de RSU |
668,416 |
- |
- |
817,602 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
